Vasopressin V(1) receptor-mediated activation of central sympatho-adrenomedullary outflow in rats (Q44235404)

1 December 2017

title

Vasopressin V(1) receptor-mediated activation of central sympatho-adrenomedullary outflow in rats (English)

1 reference

1 December 2017

0 references

Shoshiro Okada

1

1 reference

1 December 2017

Yoshinori Murakami

series ordinal

2

1 reference

1 December 2017

Kumiko Nakamura

series ordinal

3

1 reference

1 December 2017

Kunihiko Yokotani

series ordinal

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

European Journal of Pharmacology

1 December 2017

published in

1 reference

1 December 2017

volume

457

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

29-35

1 reference

Neurohypophysial peptide systems: processing machinery, hydroosmotic regulation, adaptation and evolution

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Novel Ligand Specificity of Pituitary Vasopressin Receptors in the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Modulation of cyclic AMP-dependent protein kinase by vasopressin and calcitonin in cultured porcine renal LLC-PK1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

A novel type of vasopressin receptor on anterior pituitary corticotrophs?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Diglyceride lipase: a pathway for arachidonate release from human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

The cloned vasopressin V1a receptor stimulates phospholipase A2, phospholipase C, and phospholipase D through activation of receptor-operated calcium channels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Excitation of the cardiac vagus by vasopressin in mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Influence of vasopressin and angiotensin on baroreflexes in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Central nervous system effects of the neurohypophyseal hormones and related peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Characterization and localization of 3H-arginine8-vasopressin binding to rat kidney and brain tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

The block of central vasopressin V1 but not V2 receptors suppresses grooming behavior and hypothermia induced by intracerebroventricular vasopressin in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

The importance of phospholipase-A2 in prostaglandin biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

The influence of the paraventriculo-spinal pathway, and oxytocin and vasopressin on sympathetic preganglionic neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

How is the level of free arachidonic acid controlled in mammalian cells?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Central command neurons of the sympathetic nervous system: basis of the fight-or-flight response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Central vasopressin in the modulation of catecholamine release in conscious rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Vasopressin acting at V1-type receptors produces membrane depolarization in neonatal rat spinal lateral column neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): A potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

[1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response t

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Molecular biology of vasopressin receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

No requirement of cyclic conformation of antagonists in binding to vasopressin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Plasma catecholamines in conscious rabbits after central administration of vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Nitric oxide mediates central activation of sympathetic outflow induced by interleukin-1 beta in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Thromboxane A2 is involved in the nitric oxide-induced central activation of adrenomedullary outflow in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Roles of brain prostaglandin E2 and thromboxane A2 in the activation of the central sympatho-adrenomedullary outflow in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Central cardiovascular effects of AVP and AVP analogs with V1, V2 and 'V3' agonistic or antagonistic properties in conscious dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Perfusion of the hypothalamic paraventricular nucleus with N-methyl-D-aspartate produces thromboxane A2 and centrally activates adrenomedullary outflow in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

CENTRAL EFFECTS OF ARGININE VASOPRESSIN ON BLOOD PRESSURE IN RATS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Paraventricular Nucleus:A Site for the Integration of Neuroendocrine and Autonomic Mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Vasopressin binding sites in the central nervous system: distribution and regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Antipyresis due to centrally administered vasopressin differentially alters thermoregulatory effectors depending on the ambient temperature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Elevation of plasma noradrenaline levels in urethane‐anaesthetized rats by activation of central prostanoid EP3 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Recombinant interleukin-1 beta inhibits gastric acid secretion by activation of central sympatho-adrenomedullary outflow in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Brain phospholipase A(2)-arachidonic acid cascade is involved in the activation of central sympatho-adrenomedullary outflow in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Role of brain arachidonic acid cascade on central CRF1 receptor-mediated activation of sympatho-adrenomedullary outflow in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Central cardiovascular effects of mammalian neurohypophyseal peptides in conscious rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

Role of central vasopressin in cardiovascular regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902652-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(02)02652-3

1 reference

1 December 2017

1 reference